(%)
| 2019/3 | 2020/3 | 2021/3 | 2022/3 | 2023/3 | ||
|---|---|---|---|---|---|---|
| Return of Equity (ROE) | Full year | 5.4 | 4.3 | -3.6 | 3.3 | 5.9 |
(%)
| 2019/3 | 2020/3 | 2021/3 | 2022/3 | 2023/3 | ||
|---|---|---|---|---|---|---|
| Equity ratio* | Full year | 34.2 | 32.1 | 48.7 | 48.7 | 43.3 |
| Q4 | 34.2 | 32.1 | 48.7 | 48.7 | 43.3 | |
| Q3 | 35.5 | 32.8 | 48.6 | 48.3 | 43.4 | |
| Q2 | 35.7 | 32.4 | 48.8 | 48.8 | 44.5 | |
| Q1 | 34.3 | 33.2 | 49.2 | 49.0 | 48.3 | |
(Yen)
| 2019/3 | 2020/3 | 2021/3 | 2022/3 | 2023/3 | ||
|---|---|---|---|---|---|---|
| Earnings per share(EPS):Basic | Full year | 68.32 | 54.58 | -45.20 | 45.35 | 88.13 |
| Dividends per share | Full year | 23.00 | 26.00 | 15.00 | 26.00 | 34.00 |
(%)
| 2019/3 | 2020/3 | 2021/3 | 2022/3 | 2023/3 | ||
|---|---|---|---|---|---|---|
| Dividend payout ratio | Full year | 33.7 | 47.6 | - | 57.3 | 38.6 |
(Million yen)
| 2019/3 | 2020/3 | 2021/3 | 2022/3 | 2023/3 | ||
|---|---|---|---|---|---|---|
| R&D Expenditure | Full year | 111,013 | 102,851 | 90,387 | 96,721 | 107,748 |
| Operating income margin | Full year | 5.5 | 5.1 | 5.4 | 5.5 | 5.0 |
(Million yen)
| 2019/3 | 2020/3 | 2021/3 | 2022/3 | 2023/3 | ||
|---|---|---|---|---|---|---|
| Capital Investments | Full year | 72,462 | 86,596 | 42,155 | 37,359 | 45,458 |
| Depreciation for tangible fixed assets | Full year | 65,437 | 62,528 | 45,389 | 39,851 | 41,995 |